DESAL PILLS 5MG
DESAL PILLS 5MG 30 tablets
Security policy (edit with Customer reassurance module)
Delivery policy (edit with Customer reassurance module)
Return policy (edit with Customer reassurance module)
To relieve or eliminate symptoms:
- allergic rhinitis (sneezing, nasal congestion, rhinorrhea, itching in the nose, itching of the sky, itching and redness of the eyes, watery eyes);
- urticaria (pruritus, rash).
Dosage and administration
Inside, regardless of the meal.
Adults and teenagers (12 years and older) - 5 mg (1 tab.) 1 time / day.
The following adverse reactions are most often noted: increased fatigue (1.2%), dryness of the oral mucosa (0.8%), headache (0.6%).
When using the drug in adults and adolescents in the recommended dose of 5 mg / day, the frequency of drowsiness is not higher than with placebo.
Very rarely in post-marketing surveillance. The following adverse reactions were noted.
Mental disorders: hallucinations.
From the side of the central nervous system: dizziness, drowsiness, insomnia, psychomotor hyperactivity.
Since the cardiovascular system: tachycardia, palpitations.
From the digestive system: abdominal pain, nausea, vomiting, dyspepsia, diarrhea.
Liver and biliary tract: increased activity of liver enzymes, increasing the concentration of bilirubin, hepatitis.
From the musculoskeletal system: myalgia.
Allergic reactions: anaphylaxis, angioedema, pruritus, rash, urticaria.
- breastfeeding period;
- children's age up to 12 years (efficiency and safety are not established);
- hypersensitivity to the active or any excipient of the drug.
WITH caution the drug should be used for severe renal failure.
Use during pregnancy and lactation
Prescription of the drug during pregnancy is not recommended due to the lack of clinical data on the safety of its use in this period.
Desloratadine is excreted in breast milk, so its use during breastfeeding is not recommended.
Application for violations of kidney function
With caution should use the drug in severe renal failure.
Use in children
It is contraindicated in children under the age of 12 years, because efficacy and safety not established.
In the case of pronounced impaired renal function, Desal should be taken with caution.
Impact on the ability to drive vehicles and mechanisms
AT Studies have not noted the effect of Desloratadine on driving. However, it should be borne in mind that it is very rare for some patients to develop drowsiness, in this case care should be taken when driving and working with mechanisms.
Symptoms: Reception in a dose exceeding recommended in 9 times (45 mg), did not lead to the appearance of any clinically significant symptoms. Perhaps the development of drowsiness.
Treatment: necessary gastric lavage, taking activated charcoal; if necessary, symptomatic therapy. Desloratadine is not excreted by hemodialysis, the effectiveness of peritoneal dialysis has not been established.
No clinically significant interaction with other drugs was revealed (including with Ketoconazole and erythromycin).
Desloratadine does not enhance the effect of ethanol on the central nervous system.
Pharmacy sales terms
The drug is approved for use as a means of OTC.
Terms and conditions of storage
The drug should be stored out of the reach of children, dry, protected from light, at a temperature not higher than 25 ° C.